-Caroline Knapp, mother of a young kidney transplant patient in the UK
In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in this content.
Mitra® Cartridges offer the easiest way to collect an accurate specimen sample. They're the ideal solution for organizations seeking to analyze the health of their employees and the impact on their insurance coverage. End-users have an easy, convenient sampling experience and labs receive high-quality samples.
For studies of substance abuse, proper organ function, and infectious diseases, remote microsampling provides an alternative to conventional specimen collection. Top researchers around the world use the Mitra cartridge to better understand medical conditions and offer solutions to improve healthcare.
The Cartridge format provides a positive study subject sampling experience, allowing high-quality specimen samples to be collected outside the facility. Native bar codes facilitate tracking of remote samples to contract research laboratories.
Make it easier for clinical research participants to stay committed without disrupting their lives. The convenience of home specimen collection promotes adherence and compliance through a safe-at-home, convenient virtual approach.
|
|
*All Cartridge configurations include bar coding |
10 µL | 20 µL | 30 µL |
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.